Suppr超能文献

快速了解肥胖:体内的敌人。

A quick look at obesity; the enemy within.

作者信息

Hassanzadeh Parichehr

机构信息

Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):186-91.

Abstract

Obesity with an increasing prevalence rate worldwide is correlated with multiple comorbidities. Unfortunately, the currently available therapies such as the pharmacotherapy, bariatric surgery or gene-transfer technology are associated with a number of disadvantages including undesirable side effects, poor compliance or transient effectiveness. Therefore, modifications of the lifestyle factors might be of great importance. Recently, neurotrophic factors and their metabotrophic potential in targeted pharmacology against obesity has been the focus of intense research. Meanwhile, because of the complexity and multi-factorial nature of obesity, it will still remain as a challenging medical problem.

摘要

肥胖在全球范围内的患病率不断上升,与多种合并症相关。不幸的是,目前可用的治疗方法,如药物治疗、减肥手术或基因转移技术,都存在一些缺点,包括不良副作用、依从性差或效果短暂。因此,改变生活方式因素可能非常重要。最近,神经营养因子及其在肥胖靶向药理学中的代谢营养潜力一直是深入研究的焦点。与此同时,由于肥胖的复杂性和多因素性质,它仍将是一个具有挑战性的医学问题。

相似文献

1
A quick look at obesity; the enemy within.
Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):186-91.
3
CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY.
J Popul Ther Clin Pharmacol. 2019 May 23;26(2):e1-e4. doi: 10.15586/jptcp.v26i2.599.
4
Current pharmacotherapy for obesity.
Nat Rev Endocrinol. 2018 Jan;14(1):12-24. doi: 10.1038/nrendo.2017.122. Epub 2017 Oct 13.
6
Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.
Postgrad Med. 2015 Jun;127(5):494-502. doi: 10.1080/00325481.2015.1048181.
9
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Pharmacotherapy for the treatment of obesity.
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 2:173-83. doi: 10.1016/j.mce.2015.09.005. Epub 2015 Sep 7.

本文引用的文献

2
Combined treatment of symptomatic massive paraesophageal hernia in the morbidly obese.
JSLS. 2011 Apr-Jun;15(2):188-92. doi: 10.4293/108680811X13022985132164.
3
Monitoring for and preventing the long-term sequelae of bariatric surgery.
J Am Acad Nurse Pract. 2011 Sep;23(9):449-58. doi: 10.1111/j.1745-7599.2011.00655.x. Epub 2011 Aug 5.
5
Obesity epidemic: overview, pathophysiology, and the intensive care unit conundrum.
JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):4S-13S. doi: 10.1177/0148607111415110.
6
Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
Curr Opin Endocrinol Diabetes Obes. 2011 Oct;18(5):321-7. doi: 10.1097/MED.0b013e32834a8726.
7
The global obesity pandemic: shaped by global drivers and local environments.
Lancet. 2011 Aug 27;378(9793):804-14. doi: 10.1016/S0140-6736(11)60813-1.
9
Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits.
Neuron. 2011 Aug 11;71(3):529-41. doi: 10.1016/j.neuron.2011.06.006.
10
Evaluation of efficacy and safety of orlistat in obese patients.
Indian J Endocrinol Metab. 2011 Apr;15(2):99-104. doi: 10.4103/2230-8210.81938.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验